Rifabutin absorption in the gut unaltered by concomitant administration of didanosine in AIDS patients.

Didanosine (ddI) is currently used in the management of patients infected by the human immunodeficiency virus. Rifabutin (RBT) is being extensively used for prophylaxis against Mycobacterium avium complex (MAC) infections. Due to its acid-labile characteristics, ddI must be administered with a buffe...

Cijeli opis

Bibliografski detalji

Izdano u:	Antimicrob Agents Chemother
Glavni autori:	Li, R C, Narang, P K, Sahai, J, Cameron, W, Bianchine, J R
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Microbiology (ASM) 1997
Teme:	Research Article
Online pristup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163960/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9210686/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.7.1566
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!